RSPKX | VSIIX | RSPKX / VSIIX | |
Total Expense Ratio | 1.69 | 0.06 | 2,817% |
Annual Report Gross Expense Ratio | 2.42 | 0.06 | 4,033% |
Fund Existence | 19 years | 26 years | - |
Gain YTD | -1.058 | 2.903 | -36% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 538M | 55.6B | 1% |
Annual Yield % from dividends | 0.03 | 2.12 | 2% |
Returns for 1 year | -3.75 | 5.59 | -67% |
Returns for 3 years | 8.00 | 31.09 | 26% |
Returns for 5 years | 39.35 | 89.04 | 44% |
Returns for 10 years | -15.69 | 102.89 | -15% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DULL | 3.92 | 0.11 | +2.89% |
MicroSectors™ Gold -3X Inverse Lvrgd ETN | |||
DHY | 2.13 | 0.02 | +0.95% |
Credit Suisse High Yield | |||
IJH | 64.36 | 0.56 | +0.88% |
iShares Core S&P Mid-Cap ETF | |||
VCEB | 63.12 | 0.16 | +0.25% |
Vanguard ESG US Corporate Bond ETF | |||
BIB | 52.55 | -0.07 | -0.14% |
ProShares Ultra Nasdaq Biotechnology |